低收入和中等收入国家的癌症生存率:挑战,需求和新兴的支持策略
Gustavo Rodrigues Dos Anjos1,2, Guilherme Falcao Machado1,2, Cassiano Pereira de Barros1,2
1Emergency and Evidence-Based Medicine Unit, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.
Frontiers in public health
|July 31, 2025
概括
癌症生存率是一个日益增长的全球健康问题. 由于医疗保健差异,低收入和中等收入国家 (LMICs) 在为癌症幸存者提供足够的护理方面面临重大挑战.
科学领域:
- 全球健康 全球健康
- 在瘤学瘤学.
- 公共卫生政策 公共卫生政策
背景情况:
- 癌症生存率是一个关键的全球健康问题,全球生存率正在上升.
- 高收入国家 (HICs) 已经建立了针对晚期影响和生活质量的幸存者计划.
- 低收入和中等收入国家 (LMICs) 在医疗保健接入,基础设施和癌症幸存者的支持系统方面面临重大差异.
研究的目的:
- 审查和综合有关LMIC癌症存活率的现有文献.
- 评估不同地区癌症幸存者护理方面的挑战和成功实践.
- 在资源有限的环境中,确定改善幸存者护理的需求和创新模式.
主要方法:
- 在LMICs中癌症存活率的系统文献综述.
- 分析包括财政障碍,有限的后续护理和心理社会差距在内的挑战.
- 评估有关LMICs晚期影响和成功干预的新兴数据.
主要成果:
- 低低收入国家在幸存者护理方面存在重大差距,特别是在非城市地区,这会影响长期的福祉.
- 已注意到内分泌/代谢障碍和慢性感染等晚期影响,但综合数据很少.
- 巴西的成功模式,如 Mais Médicos 和 DATA-SUS,为护理能力和数据注册提供了潜在的解决方案.
结论:
- 创新的护理模式,包括非营利性伙伴关系和基于社区的干预措施,对LMICs至关重要.
- 解决社会经济差距对于改善全球癌症后康复和幸存者护理至关重要.
- 需要进一步的研究和系统的跟进,特别是在LMICs的儿童癌症幸存者.
相关概念视频
01:21Cancer Survival Analysis
456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:18Cancer
49.6K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.6K
02:53Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
01:30Cancer Vaccines
514
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
514
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K